EXOZ
eXoZymes·NASDAQ
--
--(--)
--
--(--)
7.28 / 10
Outperform
Analyst coverage is absent (ana_eval -1). Fund‑flow score is 7.28/10, rated good. Overall inflow ratio is 39.5% but trend is negative; medium investors show positive flow, while block, small, large and extra‑large remain negative. Funding outlook leans positive despite mixed trends.
Fund Flow Rating
What is the analyst consensus for EXOZ?
- EXOZ holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.28/10 (Outperform).
